VEGF (Bevacizumab Biosimilar) Anticorps
(VEGF (Bevacizumab Biosimilar))
This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
VEGF (Bevacizumab Biosimilar) recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
ELISA
Validations
- (1)
N° du produit
ABIN7093077
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
FACS, in vivo
Validations
N° du produit
ABIN7200653
Quantité
1 mg
Fiche technique
Fiche technique
Reactivity
Human
Application
FACS, ELISA, WB, BR, IP
Validations
N° du produit
ABIN7487763
Quantité
200 μg
Fiche technique
Fiche technique
Synonymes et noms alternatifs relatifs à VEGF (Bevacizumab Biosimilar)
vascular endothelial growth factor A (VEGFA), MVCD1, VEGF, VPFProtein level used designations for VEGF (Bevacizumab Biosimilar)
- vascular permeability factor
Vous êtes ici:
